|
Home
>
Newsletters
>
International Pharmaceutical Regulatory Monitor
> MHRA Reminds Drug Companies to Provide Updates on Drug Statuses
International Pharmaceutical Regulatory Monitor
May 2012
| Vol.
40 No.
5
MHRA Reminds Drug Companies to Provide Updates on Drug Statuses
Companies with drugs authorized in the UK are being asked to update the Medicines and Healthcare products Regulatory Agency (MHRA) on the marketing status of their products.
|
|
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews
All rights reserved. Do not duplicate or redistribute in any form.